Comparison of Serum Adropin Levels in Patients with Diabetes Mellitus, COVID-19, and COVID-19 with Diabetes Mellitus

Creative Commons License

Aydin P., Uzuncakmak S. K., Tor I. H., Bilen A., Ozden A.

EURASIAN JOURNAL OF MEDICINE, cilt.54, sa.2, ss.197-201, 2022 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 54 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5152/eurasianjmed.2022.22128
  • Dergi Adı: EURASIAN JOURNAL OF MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.197-201
  • Anahtar Kelimeler: Adropin, COVID-19, DM, d-dimer, CRP, FLOW-MEDIATED DILATATION, REACTIVE PROTEIN-LEVELS, CLINICAL CHARACTERISTICS, ENDOTHELIAL DYSFUNCTION, SARS-COV-2 INFECTION, SEVERITY
  • Atatürk Üniversitesi Adresli: Evet

Özet

Objective: In the present study, the relationship between a poor prognosis and adropin levels in diabetic patients with coronavirus disease 2019 was investigated by measuring serum adropin levels and levels of D-dimer, C-reactive protein, and ferritin, which are considered prognostic factors for coronavirus disease 2019.